Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Lakefront Biotherapeutics NV (GXE) vs. Competitors

6 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:GXELakefront Biotherapeutics NVEUR 31.00EUR 1.96B4.209.70%Moderate SellUnlock the DE:GXE analyst price target with TipRanks PremiumDE:GXEUnlock the DE:GXE top-analyst price target with TipRanks Premium
NL:PHARMPharming GroupEUR 1.16EUR 838.72M36.48-20.10%―Unlock the NL:PHARM analyst price target with TipRanks PremiumDE:GXE vs NL:PHARMUnlock the NL:PHARM top-analyst price target with TipRanks Premium
NL:VVYVivoryon Therapeutics AGEUR 0.76EUR 22.80M-3.29-54.06%―Unlock the NL:VVY analyst price target with TipRanks PremiumDE:GXE vs NL:VVYUnlock the NL:VVY top-analyst price target with TipRanks Premium

Performance Comparison

-80%-60%-40%-20%0%20%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:GXELakefront Biotherapeutics NV31.003.9214.48%
NL:PHARMPharming Group1.16-0.33-22.03%
NL:VVYVivoryon Therapeutics AG0.76-0.88-53.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts